The global cryogenic vial market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Valued at USD 165.3 million in 2024, the market is expected to surpass USD 251.8 million by 2034, driven by a surge in demand across various sectors, including pharmaceuticals, healthcare, and biotechnology.
Key factors contributing to the market’s expansion include the rapid growth of pharmaceutical enterprises, increasing automation in production processes, and the rising geriatric population, which is expected to require more temperature-sensitive treatments and therapies.
Additionally, heightened investment from both the public and private sectors and the continued development of innovative techniques are expected to play a critical role in fueling market growth over the next decade.
Gain Comprehensive Knowledge—Read the Entire Report Now!
Cryogenic vials, known for their cryopreservation capabilities, are essential in maintaining the integrity of biological samples, such as proteins, animal tissues, and temperature-sensitive cells, which lose their chemical properties at normal temperatures.
These vials ensure that samples are stored at temperatures well below sub-zero, thereby preserving their viability and preventing degradation. The demand for cryogenic vials is expected to rise significantly due to their superior sealing performance, mobility, and their ability to preserve viruses and biological samples for extended periods.
As manufacturers adapt to evolving customer needs, the sale of cryogenic vials is expected to increase, particularly with the introduction of specialized storage bins and racks. The addition of a color-coded polypropylene cap and a silicone washer enhances the functionality of these vials, making them ideal for cryogenic processing, animal cell culture, and the conservation of animal cells.
Key Takeaways from the Cryogenic Vial Market Analysis:
- Market Size and Growth:
- The global cryogenic vial market was valued at USD 136.7 million in 2019.
- The market is projected to grow at a CAGR of 2.9% from 2019 to 2023.
- Regional Growth Projections (2024-2034):
- United States: Estimated to report a CAGR of 2.7%.
- China: Anticipated to see significant growth, with a CAGR of 5.9%.
- India: Expected to witness the highest growth, with a CAGR of 6.7%.
- Product Segmentation:
- Self-standing bottom vials are expected to dominate, accounting for 67.4% of the market share in 2024.
- End-Use Segment:
- The research organization sector is projected to lead, holding a market share of 39.3% in 2024.
Competitive Landscape
Market participants in the cryogenic vial market are expected to push the limits of manufacturing by establishing unique product portfolios that can meet a variety of user needs. The research and development of the vials’ original and unique qualities is expected to aid in the expansion of research and development techniques in other areas.
Major industry players plan to grow their global market share through a variety of strategic techniques. These may include engaging in mergers and acquisitions to strengthen their position, developing alliances with specialist markets to gain access to new client groups, and expanding their footprint in various geographic regions to catch new opportunities.
Key Players of Cryogenic Vial Industry
- Thermo Fisher Scientific Inc.
- Corning Incorporated
- DWK Life Sciences GmbH
- Sigma-Aldrich Corporation
- VWR International LLC
- Argos Technologies Inc.
- Azer Scientific Inc.
- E&K Scientific Products Inc.
- CELLTREAT Scientific Products
- BIOLOGIX GROUP LTD.
- Abdos Labtech Private Limited
Recent Industry Developments in Cryogenic Vial Market
- In May 2024, West Pharmaceutical Services launched Daikyo Crystal Zenith Nested Vials in Tub offering containment solutions for cell and gene therapies, radiopharmaceuticals, and sensitive molecules, meeting packaging demands from preclinical to commercial phases.
- In April 2024, CSafe launched a new line of cryogenic multi-use dewars for the cell and gene therapy market, maintaining temperatures colder than -150°C. These reusable dewars and high-impact-resistant shipping cases are designed to securely transport critical cell and gene therapies, ensuring the integrity of their cargo.
Key Segments of Cryogenic Vial Industry
By Material:
In terms of material, the industry is bifurcated into plastic and glass.
By Product:
In terms of products, the industry is divided into self-standing bottom and round bottom.
By Capacity:
In terms of capacity, the industry is categorized as up to 1 ml, 1.1 to 2 ml, 2 to 4 ml, and above 4 ml.
By End use:
End use industries of the sector are research organizations, drug manufacturers, and healthcare institutions.
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA), have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
